Virginia Retirement Systems Et Al Novo Cure LTD Transaction History

Virginia Retirement Systems Et Al

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$130.4 - $225.58 $717,200 - $1.24 Million	-5,500 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$124.11 - $190.17 $570,906 - $874,782	-4,600 Reduced 45.54%	5,500 $727,000
Q4 2020 Feb 16, 2021	SELL	$112.16 - $174.14 $852,416 - $1.32 Million	-7,600 Reduced 42.94%	10,100 $1.75 Million
Q3 2020 Nov 12, 2020	BUY	$58.05 - $111.31 $81,270 - $155,834	1,400 Added 8.59%	17,700 $1.97 Million
Q2 2020 Aug 12, 2020	SELL	$57.2 - $74.41 $125,840 - $163,702	-2,200 Reduced 11.89%	16,300 $967,000
Q1 2020 May 12, 2020	BUY	$57.05 - $95.75 $661,780 - $1.11 Million	11,600 Added 168.12%	18,500 $1.25 Million
Q4 2019 Jan 27, 2020	BUY	$68.3 - $93.8 $54,640 - $75,040	800 Added 13.11%	6,900 $581,000
Q3 2019 Oct 22, 2019	BUY	$61.86 - $97.8 $377,346 - $596,580	6,100 New	6,100 $456,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.